Maulik Nanavaty is of Rani Therapeutics Holdings, Inc.. Currently has a direct ownership of 500 shares of RANI, which is worth approximately $1,020. The most recent transaction as insider was on Nov 16, 2023, when has been sold 500 shares (Class A Common Stock) at a price of $1.98 per share, resulting in proceeds of $990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 500
0% 3M change
0% 12M change
Total Value Held $1,020

Maulik Nanavaty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2023
BUY
Open market or private purchase
$990 $1.98 p/Share
500 Added 50.0%
500 Class A Common Stock

Also insider at

BSX
BOSTON SCIENTIFIC CORP Healthcare
MN

Maulik Nanavaty

Marlborough, MA

Track Institutional and Insider Activities on RANI

Follow Rani Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RANI shares.

Notify only if

Insider Trading

Get notified when an Rani Therapeutics Holdings, Inc. insider buys or sells RANI shares.

Notify only if

News

Receive news related to Rani Therapeutics Holdings, Inc.

Track Activities on RANI